Introduction
The Southern Africa Regional Programme on Access to Medicines and Diagnostics (SARPAM) is a programme funded by the Department for International Development (DFID) of the United Kingdom, with the aim to assist member states of the Southern African Development Community (SADC) region to improve access to medicines.

 

Outcome
SARPAM will work to improve efficiency and competition in the market for essential medicines in the Southern African Region and thereby meet the health needs of the poor.

SARPAM was designed in consultation with the SADC Secretariat and other stakeholders, to respond to identified gaps in the pharmaceutical markets of Southern Africa, including practices which result in uncompetitive, inconsistent medicine pricing and the poor supply chain management of medicines. The programme engages both public and private sector stakeholders to ensure improved access to medicines across the region.

SARPAM uses collaborative and innovative tactics to help countries tackle regulatory and policy barriers to communities accessing medicines and seeks to enable member states of SADC partner together in finding solutions to existing challenges. Our active role in the region ranges from providing technical and policy advisory and support, research, reporting, monitoring and evaluation on medicines to facilitating dialogue among key stakeholders.